ClinicalTrials.govpublic full text
Neoadjuvant Chemoradiotherapy Plus Tislelizumab With or Without Probio-M9 in pMMR/MSS Locally Advanced Rectal Cancer
rectal cancer, adenocarcinoma, neoadjuvant therapy, immunotherapy, probio-m9, tislelizumab, randomized, locally advanced rectal cancer, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 1044983
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.